IL6 and neoplasm: Tumor-derived factors such as transforming growth factor-beta (TGF-β), interleukin-6 (IL-6), and vascular endothelial growth factor (VEGF) favor the N2 phenotype, tipping the balance toward a pro-tumorigenic state.